Study of AZD3152 Intramuscular Injection or Intravenous Infusion in Healthy Japanese Adult Participants

NCT05932641 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19, SARS-CoV-2

Interventions

BIOLOGICAL: AZD3152 (Cohort 1)
BIOLOGICAL: Placebo (Cohort 1)
BIOLOGICAL: AZD3152 (Cohort 2)
BIOLOGICAL: Placebo (Cohort 2)
BIOLOGICAL: AZD3152 (Cohort 3)
BIOLOGICAL: Placebo (Cohort 3)

Sponsor

AstraZeneca